Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1953 Dec 19;2(4850):1341–1345. doi: 10.1136/bmj.2.4850.1341

L-Noradrenaline in Treatment of Shock in Cardiac Infarction

K Shirley Smith, A Guz
PMCID: PMC2030354  PMID: 13106425

Full text

PDF
1344

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURN J. H., HUTCHEON D. E. The action of noradrenaline. Br J Pharmacol Chemother. 1949 Dec;4(4):373–380. doi: 10.1111/j.1476-5381.1949.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. KURLAND G. S., MALACH M. The clinical use of norepinephrine in the treatment of shock accompanying myocardial infarction and other conditions. N Engl J Med. 1952 Sep 11;247(11):383–389. doi: 10.1056/NEJM195209112471102. [DOI] [PubMed] [Google Scholar]
  3. MILLER A. J., BAKER L. A. 1-Arterenol (levophed) in the treatment of shock due to acute myocardial infarction. AMA Arch Intern Med. 1952 Apr;89(4):591–599. doi: 10.1001/archinte.1952.00240040070009. [DOI] [PubMed] [Google Scholar]
  4. REALE A., KAPPERT A., SKOGLUND C. H., SUTTON G. C. The effect of l-nor-adrenaline on the oxygen consumption of human beings. Acta Physiol Scand. 1950 Mar 27;20(2-3):153–159. doi: 10.1111/j.1748-1716.1950.tb00693.x. [DOI] [PubMed] [Google Scholar]
  5. SWAN H. J. C. Noradrenaline, adrenaline, and the human circulation. Br Med J. 1952 May 10;1(4766):1003–1006. doi: 10.1136/bmj.1.4766.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. WIGGERS C. J. The functional importance of coronary collaterals. Circulation. 1952 Apr;5(4):609–615. doi: 10.1161/01.cir.5.4.609. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES